These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6049299)

  • 1. In vitro antibacterial activity of kasugamycin.
    Levitan AA
    Appl Microbiol; 1967 Jul; 15(4):750-3. PubMed ID: 6049299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on in vitro activities of kasugamycin and clinically-used aminoglycoside antibiotics.
    Tamamura T; Sato K
    Jpn J Antibiot; 1999 Jan; 52(1):57-67. PubMed ID: 10202688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
    Dosler S; Karaaslan E; Alev Gerceker A
    J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
    Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
    Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
    Chartrand SA; Scribner RK; Weber AH; Welch DF; Marks MI
    Antimicrob Agents Chemother; 1983 May; 23(5):658-63. PubMed ID: 6223577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts.
    Elisha IL; Botha FS; McGaw LJ; Eloff JN
    BMC Complement Altern Med; 2017 Feb; 17(1):133. PubMed ID: 28241818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of tobramycin, an aminoglycoside antibiotic.
    Dienstag J; Neu HC
    Antimicrob Agents Chemother; 1972 Jan; 1(1):41-5. PubMed ID: 4670427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
    Ito A; Hirai K; Inoue M; Koga H; Suzue S; Irikura T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth media and assay plate material can impact on the effectiveness of cationic biocides and antibiotics against different bacterial species.
    Bock LJ; Hind CK; Sutton JM; Wand ME
    Lett Appl Microbiol; 2018 May; 66(5):368-377. PubMed ID: 29432643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin.
    Sader HS; Rhomberg PR; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):412-4. PubMed ID: 23102558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.
    Nath K; Talukdar AD; Bhattacharya MK; Bhowmik D; Chetri S; Choudhury D; Mitra A; Choudhury NA
    BMC Complement Altern Med; 2019 Oct; 19(1):279. PubMed ID: 31640666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial and antibiotic modifying activity of crude extract, fractions and 3',4',7-trihydroxyflavone from Myristica fragrans Houtt against MDR Gram-negative enteric bacteria.
    Dzotam JK; Simo IK; Bitchagno G; Celik I; Sandjo LP; Tane P; Kuete V
    BMC Complement Altern Med; 2018 Jan; 18(1):15. PubMed ID: 29334931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic.
    Cheung Lam AH; Sandoval N; Wadhwa R; Gilkes J; Do TQ; Ernst W; Chiang SM; Kosina S; Howard Xu H; Fujii G; Porter E
    BMC Res Notes; 2016 Jul; 9():337. PubMed ID: 27391402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of ethanolic and aqueous extracts of Acacia aroma Gill. ex Hook et Arn.
    Arias ME; Gomez JD; Cudmani NM; Vattuone MA; Isla MI
    Life Sci; 2004 May; 75(2):191-202. PubMed ID: 15120571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro bactericidal effectiveness of four aminoglycoside antibiotics.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1973 Jan; 3(1):87-94. PubMed ID: 4790579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model.
    Gunderson BW; Ibrahim KH; Hovde LB; Fromm TL; Reed MD; Rotschafer JC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):905-9. PubMed ID: 12604520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(3):166-200. PubMed ID: 789045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial activity of sisomicin in comparison with gentamicin].
    Scheer M
    Arzneimittelforschung; 1976; 26(5):772-8. PubMed ID: 9099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro evaluation of BL-P1654 and carbenicillin against Pseudomonas.
    Overturf GD; Ressler R; Wilkins J
    Antimicrob Agents Chemother; 1974 Nov; 6(5):643-6. PubMed ID: 15825320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.